Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Inventory (2016 - 2025)

Mimedx (MDXG) has disclosed Inventory for 15 consecutive years, with $25.3 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 6.44% to $25.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.3 million through Dec 2025, up 6.44% year-over-year, with the annual reading at $25.3 million for FY2025, 6.44% up from the prior year.
  • Inventory hit $25.3 million in Q4 2025 for Mimedx, down from $26.5 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $26.5 million in Q3 2025 to a low of $10.1 million in Q2 2021.
  • Historically, Inventory has averaged $18.4 million across 5 years, with a median of $17.9 million in 2023.
  • Biggest five-year swings in Inventory: decreased 4.05% in 2021 and later surged 66.84% in 2024.
  • Year by year, Inventory stood at $11.4 million in 2021, then rose by 15.75% to $13.2 million in 2022, then soared by 59.46% to $21.0 million in 2023, then grew by 13.25% to $23.8 million in 2024, then increased by 6.44% to $25.3 million in 2025.
  • Business Quant data shows Inventory for MDXG at $25.3 million in Q4 2025, $26.5 million in Q3 2025, and $24.9 million in Q2 2025.